Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic School of Medicine and the Mayo Clinic Medical Scientist Training Program, Rochester, MN, 55905, USA.
Department of Medical Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Support Care Cancer. 2020 Dec;28(12):5833-5838. doi: 10.1007/s00520-020-05442-9. Epub 2020 Apr 6.
The purpose of this study was to evaluate acupuncture use among breast cancer survivors, including perceived symptom improvements and referral patterns.
Breast cancer survivors who had used acupuncture for cancer- or treatment-related symptoms were identified using an ongoing prospective Mayo Clinic Breast Disease Registry (MCBDR). Additionally, Mayo Clinic electronic health records (MCEHR) were queried to identify eligible participants. All received a mailed consent form and survey including acupuncture-related questions about acupuncture referrals, delivery, and costs. Respondents were also asked to recall symptom severity before and after acupuncture treatment and time to benefit on Likert scales.
Acupuncture use was reported among 415 participants (12.3%) of the MCBDR. Among MCBDR and MCEHR eligible participants, 241 women returned surveys. A total of 193 (82.1%) participants reported a symptomatic benefit from acupuncture, and 57 (24.1% of participants) reported a "substantial benefit" or "totally resolved my symptoms" (corresponding to 4 and 5 on the 5-point Likert scale). The mean symptom severity decreased by at least 1 point of the 5-point scale for each symptom; the percentage of patients who reported an improvement in symptoms ranged from 56% (lymphedema) to 79% (headache). The majority of patients reported time to benefit as "immediate" (34%) or "after a few treatments" (40.4%). Over half of the participants self-referred for treatment; 24.1% were referred by their oncologist. Acupuncture delivery was more frequent in private offices (61.0%) than in hospital or medical settings (42.3%). Twelve participants (5.1%) reported negative side effects, such as discomfort.
Acupuncture is commonly utilized by patients for a variety of breast cancer-related symptoms. However, patients frequently self-refer for acupuncture treatments, and most acupuncture care is completed at private offices, rather than medical clinic or hospital settings.
本研究旨在评估乳腺癌幸存者对针灸的使用情况,包括对症状改善的感知和转诊模式。
使用正在进行的梅奥诊所乳腺疾病登记处(MCBDR)确定曾因癌症或治疗相关症状使用过针灸的乳腺癌幸存者。此外,还通过梅奥诊所电子健康记录(MCEHR)查询了符合条件的参与者。所有参与者都收到了一份邮寄的同意书和调查问卷,内容包括关于针灸转诊、治疗和费用的相关问题。受访者还被要求在李克特量表上回忆针灸治疗前后的症状严重程度和获益时间。
MCBDR 中有 415 名参与者(12.3%)报告了针灸的使用情况。在 MCBDR 和 MCEHR 合格参与者中,有 241 名女性返回了调查。共有 193 名(82.1%的参与者)报告了针灸的症状改善,57 名(24.1%的参与者)报告了“显著改善”或“完全缓解了我的症状”(对应于 5 分制中的 4 分和 5 分)。每个症状的严重程度至少降低了 1 分;报告症状改善的患者比例从 56%(淋巴水肿)到 79%(头痛)不等。大多数患者报告获益时间为“立即”(34%)或“治疗几次后”(40.4%)。超过一半的参与者自行寻求治疗;24.1%是由肿瘤医生转诊的。私人诊所(61.0%)比医院或医疗场所(42.3%)更频繁地进行针灸治疗。12 名患者(5.1%)报告了负面副作用,如不适。
针灸被患者广泛用于治疗各种乳腺癌相关症状。然而,患者经常自行寻求针灸治疗,而且大多数针灸治疗都是在私人诊所进行的,而不是在医疗诊所或医院进行。